Lupin to acquire VISUfarma for €190 million, enhancing its European presence and ophthalmology portfolio with over 60 eye health products.
Dividend stocks this week, September 28: Glenmark Pharma trades ex-dividend on Oct 3; watch for interim Rs 2.5 payout. Check…
Indian benchmark indices, Sensex and Nifty, extended their losing streak to a sixth session on Friday, dropping nearly 1% and…
Nifty Pharma index drops over 2% after Trump unveils 100% tariff on drug imports – see which stocks are most…
Natco Pharma plans to demerge its agro business from core pharma to unlock value, enhance focus, and ensure dedicated management.
Discover why Nomura predicts a 25% downside for Glenmark Pharma despite its new cancer drug deal—read their analysis before investing!
Government clarifies re-labelling of medicines is not mandatory as new GST rates take effect from September 22.
His latest order identifies more than 45 categories for zero import tariffs from “aligned partners” who clinch framework pacts to…
With increasing government policy support, innovation, and digitalisation, many Indian businesses are growing at a fast pace. Here are three…
India’s $3 bn contract research, development and manufacturing (CRDMO) sector is set to grow at 18% CAGR till FY30, says…
Allowing data exclusivity would prevent the drug regulator — Central Drugs Standard Control Organisation — from granting marketing approval for…
India’s July exports rose 7.3% to $37.24 bn on strong US sales, but imports surged, widening the trade deficit to…
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong specialty…
Tarun Mathur, CTO of Indegene, on how pharma firms can responsibly scale GenAI, the guardrails needed for compliance, and emerging…
Elara Capital observes that Aurobindo Pharma has 14 biosimilars in the pipeline. The company has also filed 3 biosimilars for…
The US has imposed a steep 25 per cent tariff on Indian goods, targeting key export sectors like textiles, diamonds,…
Sun Pharma slides 6% after weak Q1 FY26 results, but Motilal Oswal still recommends Buy—discover the three reasons to consider…
The White House has extended key tariff exemptions under Executive Order 14257, shielding sectors like copper, steel, pharmaceuticals, and auto…